Rakisheva A 2
51. Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors. A Clinical Consensus Statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio-Oncology
52. Quality of life in heart failure and implantable cardioverter defibrillator patients: time to close the gap in holistic care
53. The Role of Sodium Zirconium Cyclosilicate in Optimizing Heart Failure Therapy
54. COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology
55. Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC
56. Management of cardiac emergencies in women: a clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the Heart Failure Association (HFA), and the European Heart Rhythm Association (EHRA) of the ESC, and the ESC Working Group on Cardiovascular Pharmacotherapy
57. Exploring gender equity in higher education pedagogy: A co-constructed comparative case study of Kazakhstan and India
58. Gendered Aspects of Undergraduate Student Experience in the Time of COVID-19: A Case Study of Nazarbayev University
59. How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC
60. 2025 ESC Guidelines for the management of myocarditis and pericarditis
61. Insights into the European heart failure epidemiology
62. Insights into the European heart failure epidemiology
63. Insights into the European heart failure epidemiology
64. The European heart failure management resources, treatment reimbursement and activities of professional and patient organizations
65. The Heart Failure Association Atlas: Heart Failure Epidemiology and Management Statistics 2019
66. Effects of Glucagon-like Peptide-1 Receptor Agonists on Cardiac Function, Exercise Capacity and Quality of Life
67. Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT
68. Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT
69. Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT
70. Living with peripartum cardiomyopathy: A statement from the Heart Failure Association and the Association of Cardiovascular Nursing and Allied Professions of the European Society of Cardiology
71. Profiling hypotension in heart failure based on office, orthostatic and ambulatory blood pressure measurements
72. 2021 ESC/EACTS Guidelines for the management of valvular heart disease
73. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
74. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
75. Assessment of frailty in patients with heart failure: A new Heart Failure Frailty Score developed by Delphi consensus
76. Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology
77. Quality of life in heart failure. the heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology
78. 2024 ESC Guidelines for the management of chronic coronary syndromes
79. Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity?
80. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
1 2 2